DK3567034T3 - Pentacyclothienyl- og indanyl-urinstof-derivater som kaliumkanalåbnere - Google Patents

Pentacyclothienyl- og indanyl-urinstof-derivater som kaliumkanalåbnere Download PDF

Info

Publication number: DK3567034T3
Authority: DK; Denmark
Prior art keywords: pentacyclothienyl; indanyl; potassium channel; channel openers; urine derivatives
Prior art date: 2017-02-28

Application number

DK19179900.6T

Other languages

English (en)

Inventor

Michael Bös

Original Assignee

Acousia Therapeutics Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-02-28

Filing date

2018-02-27

Publication date

2021-01-11

2018-02-27 Application filed by Acousia Therapeutics Gmbh filed Critical Acousia Therapeutics Gmbh

2021-01-11 Application granted granted Critical

2021-01-11 Publication of DK3567034T3 publication Critical patent/DK3567034T3/da

Links

-1 INDANYL Chemical class 0.000 title 1
229940127315 Potassium Channel Openers Drugs 0.000 title 1
210000002700 urine Anatomy 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Fertilizers (AREA)
Cosmetics (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

DK19179900.6T 2017-02-28 2018-02-27 Pentacyclothienyl- og indanyl-urinstof-derivater som kaliumkanalåbnere DK3567034T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP17158326.3A EP3366683A1 (en)	2017-02-28	2017-02-28	Cyclic amides, acteamides and ureas useful as potassium channel openers
EP18707374.7A EP3484863B1 (en)	2017-02-28	2018-02-27	Cyclic amides as potassium channel openers

Publications (1)

Publication Number	Publication Date
DK3567034T3 true DK3567034T3 (da)	2021-01-11

Family

ID=58192162

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK19179900.6T DK3567034T3 (da)	2017-02-28	2018-02-27	Pentacyclothienyl- og indanyl-urinstof-derivater som kaliumkanalåbnere
DK18707374.7T DK3484863T3 (da)	2017-02-28	2018-02-27	Cykliske amider som kaliumkanalåbnere

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK18707374.7T DK3484863T3 (da)	2017-02-28	2018-02-27	Cykliske amider som kaliumkanalåbnere

Country Status (25)

Country	Link
US (2)	US11034665B2 (da)
EP (3)	EP3366683A1 (da)
JP (3)	JP6795713B2 (da)
KR (2)	KR102382795B1 (da)
CN (2)	CN110312710B (da)
AU (2)	AU2018227005B2 (da)
BR (2)	BR122020025103B1 (da)
CA (2)	CA3238405A1 (da)
CL (2)	CL2019002445A1 (da)
CY (2)	CY1123114T1 (da)
DK (2)	DK3567034T3 (da)
ES (2)	ES2846772T3 (da)
HR (2)	HRP20201159T1 (da)
HU (2)	HUE052703T2 (da)
IL (1)	IL268931B (da)
LT (2)	LT3567034T (da)
MX (2)	MX390303B (da)
PH (1)	PH12019550146A1 (da)
PL (2)	PL3484863T3 (da)
PT (2)	PT3484863T (da)
RS (2)	RS60648B1 (da)
SI (2)	SI3567034T1 (da)
SM (2)	SMT202100053T1 (da)
WO (1)	WO2018158256A2 (da)
ZA (1)	ZA201905198B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3366683A1 (en) *	2017-02-28	2018-08-29	Acousia Therapeutics GmbH	Cyclic amides, acteamides and ureas useful as potassium channel openers
CA3176526A1 (en)	2020-04-29	2021-11-04	Idorsia Pharmaceuticals Ltd	Spirourea derivatives
MX2022016263A (es)	2020-06-25	2023-02-09	Idorsia Pharmaceuticals Ltd	Derivados de ciclobutil-urea.
MX2023005822A (es)	2020-11-19	2023-05-31	Acousia Therapeutics Gmbh	Composicion de gel no acuoso.
EP4279061A1 (en) *	2022-05-18	2023-11-22	Acousia Therapeutics GmbH	Aqueous gel composition

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0594034A (ja)	1990-06-29	1993-04-16	Xerox Corp	クラツクのない電子写真画像形成デバイス
ATE228119T1 (de) *	1998-04-15	2002-12-15	Pfizer Prod Inc	Heterocyclische carboxamide
DE19929076A1 (de) *	1999-06-25	2000-12-28	Aventis Pharma Gmbh	Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10061876A1 (de) *	2000-12-12	2002-06-20	Aventis Pharma Gmbh	Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
AR033095A1 (es)	2001-04-04	2003-12-03	Wyeth Corp	Metodos para el tratamiento de motilidad gastrica hiperactiva
US7273866B2 (en) *	2002-12-20	2007-09-25	Bristol-Myers Squibb Company	2-aryl thiazole derivatives as KCNQ modulators
AU2004222626B2 (en)	2003-03-21	2010-06-24	H. Lundbeck A/S	Substituted p-diaminobenzene derivatives
TWI357901B (en) *	2004-03-12	2012-02-11	Lundbeck & Co As H	Substituted morpholine and thiomorpholine derivati
UA89503C2 (uk)	2004-09-13	2010-02-10	Х. Луннбек А/С	Заміщені похідні аніліну
US20060188445A1 (en)	2005-02-22	2006-08-24	Fred Hutchinson Cancer Research Center	Assay for compounds that protect against sensory hair cell death and compounds identified by same
US7790770B2 (en) *	2005-11-23	2010-09-07	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
WO2007087424A2 (en)	2006-01-25	2007-08-02	The Johns Hopkins University	Method of treating kcnq related disorders using organozinc compounds
WO2007138112A2 (en)	2006-06-01	2007-12-06	Devgen N.V.	Compounds that interact with ion channels, in particular with ion channels from the kv family
US20090118274A1 (en)	2007-02-15	2009-05-07	Darin Allen	Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
DE102007063673B4 (de)	2007-07-10	2018-02-08	Heraeus Electro-Nite International N.V.	Messverfahren
UA97847C2 (ru) *	2007-08-01	2012-03-26	Х. Луннбек А/С	Применение соединений, которые открывают калиевые каналы kcnq, для лечения дефицита внимания/гиперактивности (adhd) или агрессии
KR20100072077A (ko)	2007-10-17	2010-06-29	사노피-아벤티스	치환된 ｎ페닐비피롤리딘 카복스아미드 및 이의 치료적 용도
AU2008335709A1 (en) *	2007-12-13	2009-06-18	Amgen Inc.	Gamma secretase modulators
US7786171B2 (en) *	2008-04-04	2010-08-31	Abbott Laboratories	Amide derivatives as positive allosteric modulators and methods of use thereof
TW201038572A (en)	2009-03-25	2010-11-01	Gruenenthal Gmbh	Substituted spiro-amide compounds
AR078126A1 (es) *	2009-06-04	2011-10-19	Merz Pharma Gmbh & Co Kgaa	Antagonistas de glicina b, composiciones farmaceuticas, usos y proceso de preparacion de los mismos
WO2011085351A2 (en) *	2010-01-11	2011-07-14	The Johns Hopkins University	Method of treating kcnq related disorders
DE102010007281A1 (de)	2010-02-08	2011-08-11	EMC microcollections GmbH, 72070	Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
US8586604B2 (en)	2010-08-20	2013-11-19	Boehringer Ingelheim International Gmbh	Inhibitors of the microsomal prostaglandin E2 synthase-1
TW201217312A (en)	2010-09-22	2012-05-01	Gruenenthal Gmbh	Substituted benzamide compounds
WO2013126856A1 (en) *	2012-02-23	2013-08-29	Vanderbilt University	Substituted 5-aminothieno[2,3-c]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m4
US9416141B2 (en)	2012-09-28	2016-08-16	University Of Washington Through Its Center For Commercialization	Compounds and methods for preventing, treating and/or protecting against sensory hair cell death
WO2014079850A1 (en)	2012-11-23	2014-05-30	F. Hoffmann-La Roche Ag	Substituted heterocyclic derivatives
US9572815B2 (en) *	2013-03-15	2017-02-21	St. Jude Children's Research Hospital	Methods and compositions of p27KIP1 transcriptional modulators
PL404138A1 (pl) *	2013-05-31	2014-12-08	Warszawski Uniwersytet Medyczny	Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
US20150126507A1 (en) *	2013-09-05	2015-05-07	Fate Therapeutics, Inc.	Compounds to treat hearing loss
KR20160070162A (ko) *	2013-11-05	2016-06-17	에프. 호프만-라 로슈 아게	자가면역 질병의 치료를 위한 RORc 조절인자로서 5,6,7,8-테트라하이드로-5,8-메타노신놀린 유도체
EP2871181B1 (en) *	2013-11-12	2016-10-05	Acousia Therapeutics GmbH	Novel Compounds for Regeneration of Terminally-Differentiated Cells and tissues
CN105017085B (zh)	2014-04-28	2018-06-29	中国科学院上海药物研究所	一类kcnq钾通道激动剂、其制备方法和用途
CA2974395C (en) *	2015-02-06	2023-08-22	University Of Washington	Compounds and methods for preventing or treating sensory hair cell death
GB201601301D0 (en)	2016-01-25	2016-03-09	Takeda Pharmaceutical	Novel compounds
EP3366683A1 (en)	2017-02-28	2018-08-29	Acousia Therapeutics GmbH	Cyclic amides, acteamides and ureas useful as potassium channel openers

2017
- 2017-02-28 EP EP17158326.3A patent/EP3366683A1/en not_active Withdrawn
2018
- 2018-02-27 RS RS20200895A patent/RS60648B1/sr unknown
- 2018-02-27 ES ES19179900T patent/ES2846772T3/es active Active
- 2018-02-27 CN CN201880014217.4A patent/CN110312710B/zh active Active
- 2018-02-27 JP JP2019567399A patent/JP6795713B2/ja active Active
- 2018-02-27 LT LTEP19179900.6T patent/LT3567034T/lt unknown
- 2018-02-27 US US16/487,933 patent/US11034665B2/en active Active
- 2018-02-27 EP EP19179900.6A patent/EP3567034B1/en active Active
- 2018-02-27 BR BR122020025103-4A patent/BR122020025103B1/pt active IP Right Grant
- 2018-02-27 SI SI201830189T patent/SI3567034T1/sl unknown
- 2018-02-27 EP EP18707374.7A patent/EP3484863B1/en active Active
- 2018-02-27 SI SI201830113T patent/SI3484863T1/sl unknown
- 2018-02-27 MX MX2020010866A patent/MX390303B/es unknown
- 2018-02-27 AU AU2018227005A patent/AU2018227005B2/en active Active
- 2018-02-27 MX MX2019010169A patent/MX378574B/es unknown
- 2018-02-27 DK DK19179900.6T patent/DK3567034T3/da active
- 2018-02-27 CN CN202111376413.6A patent/CN114105942B/zh active Active
- 2018-02-27 CA CA3238405A patent/CA3238405A1/en active Pending
- 2018-02-27 HU HUE19179900A patent/HUE052703T2/hu unknown
- 2018-02-27 KR KR1020197023369A patent/KR102382795B1/ko active Active
- 2018-02-27 KR KR1020217035304A patent/KR102443685B1/ko active Active
- 2018-02-27 CA CA3052359A patent/CA3052359A1/en active Pending
- 2018-02-27 PL PL18707374T patent/PL3484863T3/pl unknown
- 2018-02-27 PL PL19179900T patent/PL3567034T3/pl unknown
- 2018-02-27 RS RS20201546A patent/RS61254B1/sr unknown
- 2018-02-27 SM SM20210053T patent/SMT202100053T1/it unknown
- 2018-02-27 ES ES18707374T patent/ES2813064T3/es active Active
- 2018-02-27 WO PCT/EP2018/054820 patent/WO2018158256A2/en active Application Filing
- 2018-02-27 LT LTEP18707374.7T patent/LT3484863T/lt unknown
- 2018-02-27 DK DK18707374.7T patent/DK3484863T3/da active
- 2018-02-27 BR BR112019017184-3A patent/BR112019017184B1/pt active IP Right Grant
- 2018-02-27 SM SM20200471T patent/SMT202000471T1/it unknown
- 2018-02-27 HU HUE18707374A patent/HUE051854T2/hu unknown
- 2018-02-27 PT PT187073747T patent/PT3484863T/pt unknown
- 2018-02-27 PT PT191799006T patent/PT3567034T/pt unknown
2019
- 2019-08-06 ZA ZA2019/05198A patent/ZA201905198B/en unknown
- 2019-08-19 PH PH12019550146A patent/PH12019550146A1/en unknown
- 2019-08-26 IL IL268931A patent/IL268931B/en unknown
- 2019-08-26 CL CL2019002445A patent/CL2019002445A1/es unknown
2020
- 2020-07-09 CY CY20201100634T patent/CY1123114T1/el unknown
- 2020-07-23 HR HRP20201159TT patent/HRP20201159T1/hr unknown
- 2020-09-29 JP JP2020163507A patent/JP2021008479A/ja not_active Withdrawn
- 2020-11-09 CY CY20201101052T patent/CY1123488T1/el unknown
- 2020-12-07 HR HRP20201961TT patent/HRP20201961T1/hr unknown
2021
- 2021-05-11 US US17/316,823 patent/US11884642B2/en active Active
- 2021-05-12 CL CL2021001243A patent/CL2021001243A1/es unknown
- 2021-10-22 AU AU2021254653A patent/AU2021254653B2/en active Active
2022
- 2022-08-01 JP JP2022122598A patent/JP7474289B2/ja active Active

Also Published As

Publication number	Publication date
MX378574B (es)	2025-03-10
KR102382795B1 (ko)	2022-04-05
JP2022166055A (ja)	2022-11-01
HUE051854T2 (hu)	2021-03-29
BR112019017184A2 (pt)	2020-04-28
JP2021008479A (ja)	2021-01-28
EP3366683A1 (en)	2018-08-29
ES2813064T3 (es)	2021-03-22
AU2018227005A1 (en)	2019-08-22
ES2846772T3 (es)	2021-07-29
RU2020140167A (ru)	2020-12-16
EP3484863B1 (en)	2020-06-17
LT3484863T (lt)	2020-07-27
RU2019127116A (ru)	2021-03-30
RU2020140167A3 (da)	2021-04-23
MX2019010169A (es)	2019-10-21
RU2019127116A3 (da)	2021-03-31
MX390303B (es)	2025-03-20
AU2018227005B2 (en)	2021-11-11
RS61254B1 (sr)	2021-01-29
DK3484863T3 (da)	2020-09-07
EP3567034A1 (en)	2019-11-13
ZA201905198B (en)	2020-03-25
CY1123488T1 (el)	2022-03-24
LT3567034T (lt)	2020-12-10
HRP20201159T1 (hr)	2020-11-13
CA3238405A1 (en)	2018-09-07
IL268931A (en)	2019-10-31
US20210261518A1 (en)	2021-08-26
SMT202100053T1 (it)	2021-03-15
CN110312710B (zh)	2022-02-15
KR102443685B1 (ko)	2022-09-15
US20200157072A1 (en)	2020-05-21
JP6795713B2 (ja)	2020-12-02
CL2021001243A1 (es)	2021-10-22
SMT202000471T1 (it)	2020-11-10
CL2019002445A1 (es)	2020-03-13
HUE052703T2 (hu)	2021-05-28
PT3484863T (pt)	2020-08-27
JP2020510694A (ja)	2020-04-09
CA3052359A1 (en)	2018-09-07
WO2018158256A3 (en)	2018-12-13
CN114105942B (zh)	2024-07-12
CN110312710A (zh)	2019-10-08
CN114105942A (zh)	2022-03-01
PL3484863T3 (pl)	2020-12-14
WO2018158256A2 (en)	2018-09-07
IL268931B (en)	2021-10-31
KR20190105058A (ko)	2019-09-11
PT3567034T (pt)	2020-12-04
MX2020010866A (es)	2022-02-28
AU2021254653B2 (en)	2022-12-08
RS60648B1 (sr)	2020-09-30
KR20210134826A (ko)	2021-11-10
SI3567034T1 (sl)	2021-03-31
SI3484863T1 (sl)	2020-10-30
JP7474289B2 (ja)	2024-04-24
US11884642B2 (en)	2024-01-30
BR122020025103B1 (pt)	2021-06-01
US11034665B2 (en)	2021-06-15
HRP20201961T1 (hr)	2021-02-05
CY1123114T1 (el)	2021-10-29
BR112019017184B1 (pt)	2021-06-01
AU2021254653A1 (en)	2021-11-18
EP3484863A2 (en)	2019-05-22
PL3567034T3 (pl)	2021-05-17
PH12019550146A1 (en)	2020-06-08
EP3567034B1 (en)	2020-10-28

Publication	Publication Date	Title
DK3580220T3 (da)	2022-01-10	Aminotriazolpyridiner som kinasehæmmere
EP3222107A4 (en)	2018-07-25	Channel access mechanism
DK3567034T3 (da)	2021-01-11	Pentacyclothienyl- og indanyl-urinstof-derivater som kaliumkanalåbnere
DK3704118T3 (da)	2022-03-14	Aminoimidazopyrazin som kinasehæmmere
EP3522118A4 (en)	2019-10-09	GATE DEVICE
EP3370633A4 (en)	2019-10-30	ORTHOPEDIC FASTENER, HOLDER AND GUIDANCE
EP3127162A4 (en)	2017-11-22	Germanium tin channel transistors
EP3243997B8 (de)	2019-06-12	Fluchttür
RS64479B1 (sr)	2023-09-29	Derivati alkohola kao otvarači kv7 kalijumovih kanala
DK3572405T3 (da)	2023-10-16	Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer
EP3210969A4 (en)	2018-03-28	Kcnq2-5 channel activator
DK3372671T3 (da)	2022-01-24	Dyrkningsmedium, som omfatter oligopeptider
DK3545158T3 (da)	2021-01-11	Rulleport
KR101881983B1 (ko)	2018-07-25	새로운 유형의 kcnq 칼륨 통로 작동제, 그의 제조 방법 및 그의 용도
EP3728570A4 (en)	2022-01-26	Glycoengineering
DK3571193T3 (da)	2022-01-17	Potassium Channel Modulators
EP3238267A4 (en)	2018-09-05	Thin channel region on wide subfin
IT201700055726A1 (it)	2018-11-23	Porta scorrevole.
DK3191081T3 (da)	2020-06-15	Formulering, som omfatter glycopyrrolat, fremgangsmåde og indretning
DK3632413T3 (da)	2024-12-16	Langtidscirkulerende liposom, som er modificeret med c(rgd-acp-k)
IT201700103279A1 (it)	2019-03-15	Finestra basculante
EP3601989A4 (en)	2020-11-11	VERTICAL AERODYNAMIC TUNNEL OPEN
EP3854876A4 (en)	2022-11-30	MODIFIED CHANNEL RHODOPSIN
EP3123786A4 (en)	2017-12-06	Channel scan based on mobility state
GB201717786D0 (en)	2017-12-13	Potassium channel inhibitors